{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:22:35Z","timestamp":1780510955477,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2024QN062"],"award-info":[{"award-number":["TJWJ2024QN062"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-052B"],"award-info":[{"award-number":["TJYXZDXK-052B"]}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["H2023073"],"award-info":[{"award-number":["H2023073"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10072-025-08014-z","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T03:29:12Z","timestamp":1739158152000},"page":"2129-2135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between plasma epidermal growth factor and follow-up cognitive decline in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-1128","authenticated-orcid":false,"given":"Lihua","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"9996","key":"8014_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet (London England) 386(9996):896\u2013912","journal-title":"Lancet (London England)"},{"issue":"2","key":"8014_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mds.25664","volume":"29","author":"GW Duncan","year":"2014","unstructured":"Duncan GW, Khoo TK, Yarnall AJ, O\u2019Brien JT, Coleman SY, Brooks DJ et al (2014) Health-related quality of life in early Parkinson\u2019s disease: the impact of nonmotor symptoms. Mov Disorders: Official J Mov Disorder Soc 29(2):195\u2013202","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"3","key":"8014_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","volume":"80","author":"TK Khoo","year":"2013","unstructured":"Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O\u2019Brien JT, Brooks DJ et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276\u2013281","journal-title":"Neurology"},{"issue":"10","key":"8014_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20(10):1255\u20131263","journal-title":"Mov Disord"},{"issue":"11","key":"8014_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW et al (2013) The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84(11):1258\u20131264","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"8014_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","volume":"70","author":"KF Pedersen","year":"2013","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson Disease. Jama Neurol 70(5):580\u2013586","journal-title":"Jama Neurol"},{"issue":"3","key":"8014_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0891988717701001","volume":"30","author":"KA Wyman-Chick","year":"2017","unstructured":"Wyman-Chick KA, Martin PK, Barrett MJ, Manning CA, Sperling SA (2017) Diagnostic accuracy and confidence in the clinical detection of cognitive impairment in early-stage Parkinson Disease. J Geriatr Psychiatr Neurol 30(3):178\u2013183","journal-title":"J Geriatr Psychiatr Neurol"},{"issue":"1","key":"8014_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0301-0082(96)00046-9","volume":"51","author":"M Yamada","year":"1997","unstructured":"Yamada M, Ikeuchi T, Hatanaka H (1997) The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol 51(1):19\u201337","journal-title":"Prog Neurobiol"},{"issue":"24","key":"8014_CR9","doi-asserted-by":"publisher","first-page":"18297","DOI":"10.1074\/jbc.M001965200","volume":"275","author":"RW Wong","year":"2000","unstructured":"Wong RW, Kwan RW, Mak PH, Mak KK, Sham MH, Chan SY (2000) Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice. J Biol Chem 275(24):18297\u201318301","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"8014_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cytogfr.2004.01.004","volume":"15","author":"RWC Wong","year":"2004","unstructured":"Wong RWC, Guillaud L (2004) The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15(2\u20133):147\u2013156","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"8014_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03073.x","volume":"93","author":"Y Iwakura","year":"2005","unstructured":"Iwakura Y, Piao YS, Mizuno M, Takei N, Kakita A, Takahashi H et al (2005) Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson\u2019s disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem 93(4):974\u2013983","journal-title":"J Neurochem"},{"issue":"4","key":"8014_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.22271","volume":"69","author":"AS Chen-Plotkin","year":"2011","unstructured":"Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI et al (2011) Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol 69(4):655\u2013663","journal-title":"Ann Neurol"},{"issue":"12","key":"8014_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc 30(12):1591\u20131601","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"15","key":"8014_CR14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc 25(15):2649\u20132653","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"19","key":"8014_CR15","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","volume":"75","author":"JC Dalrymple-Alford","year":"2010","unstructured":"Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP et al (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75(19):1717\u20131725","journal-title":"Neurology"},{"issue":"5","key":"8014_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1212\/WNL.0b013e3181e7948a","volume":"75","author":"M Kasten","year":"2010","unstructured":"Kasten M, Bruggemann N, Schmidt A, Klein C (2010) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 75(5):478 author reply\u2013\u20099","journal-title":"Neurology"},{"issue":"12","key":"8014_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc 22(12):1689\u20131707 quiz 837","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"4\u20136","key":"8014_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000496454","volume":"47","author":"A Faust-Socher","year":"2019","unstructured":"Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ et al (2019) Responsiveness to change of the Montreal Cognitive Assessment, Mini-mental State Examination, and SCOPA-Cog in non-demented patients with Parkinson\u2019s Disease. Dement Geriatr Cogn Disord 47(4\u20136):187\u2013197","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"8014_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/cercor\/bhu237","volume":"26","author":"H Shu","year":"2016","unstructured":"Shu H, Shi Y, Chen G, Wang Z, Liu D, Yue C et al (2016) Opposite neural trajectories of apolipoprotein E \u03f54 and \u03f52 alleles with Aging Associated with different risks of Alzheimer\u2019s Disease. Cereb Cortex 26(4):1421\u20131429","journal-title":"Cereb Cortex"},{"issue":"3","key":"8014_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10072-022-06490-1","volume":"44","author":"X Shi","year":"2023","unstructured":"Shi X, Zheng J, Ma J, Li D, Gu Q, Chen S et al (2023) Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson\u2019s disease patients. Neurol Sci 44(3):881\u2013887","journal-title":"Neurol Sci"},{"issue":"2","key":"8014_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00415-012-6648-6","volume":"260","author":"MT Pellecchia","year":"2013","unstructured":"Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C et al (2013) Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson\u2019s disease patients. J Neurol 260(2):438\u2013444","journal-title":"J Neurol"},{"issue":"5","key":"8014_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/acn3.299","volume":"3","author":"NS Lim","year":"2016","unstructured":"Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D et al (2016) Plasma EGF and cognitive decline in Parkinson\u2019s disease and Alzheimer\u2019s disease. Ann Clin Transl Neurol 3(5):346\u2013355","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"8014_CR23","doi-asserted-by":"publisher","first-page":"e29868","DOI":"10.1371\/journal.pone.0029868","volume":"7","author":"M Bj\u00f6rkqvist","year":"2012","unstructured":"Bj\u00f6rkqvist M, Ohlsson M, Minthon L, Hansson O (2012) Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer\u2019s disease. PLoS ONE 7(1):e29868","journal-title":"PLoS ONE"},{"issue":"3","key":"8014_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.neurobiolaging.2009.03.011","volume":"32","author":"J Marksteiner","year":"2011","unstructured":"Marksteiner J, Kemmler G, Weiss EM, Knaus G, Ullrich C, Mechtcheriakov S et al (2011) Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging 32(3):539\u2013540","journal-title":"Neurobiol Aging"},{"key":"8014_CR25","doi-asserted-by":"crossref","unstructured":"Purba ER, Saita EI, Maruyama IN (2017) Activation of the EGF receptor by Ligand Binding and oncogenic mutations: the Rotation Model. Cells.;6(2)","DOI":"10.3390\/cells6020013"},{"issue":"34","key":"8014_CR26","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1016\/j.biomaterials.2013.07.100","volume":"34","author":"C Yewale","year":"2013","unstructured":"Yewale C, Baradia D, Vhora I, Patil S, Misra A (2013) Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 34(34):8690\u20138707","journal-title":"Biomaterials"},{"key":"8014_CR27","doi-asserted-by":"crossref","unstructured":"Romano R, Bucci C (2020) Role of EGFR in the nervous system. Cells.;9(8)","DOI":"10.3390\/cells9081887"},{"issue":"1","key":"8014_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0006-8993(03)02234-0","volume":"968","author":"J Goggi","year":"2003","unstructured":"Goggi J, Pullar IA, Carney SL, Bradford HF (2003) Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res 968(1):156\u2013161","journal-title":"Brain Res"},{"issue":"2","key":"8014_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1471-4159.2005.03242.x","volume":"94","author":"M Itakura","year":"2005","unstructured":"Itakura M, Yamamori S, Kuwahara R, Sekiguchi M, Takahashi M (2005) Two distinct regulatory mechanisms of neurotransmitter release by phosphatidylinositol 3-kinase. J Neurochem 94(2):502\u2013509","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"8014_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cytogfr.2004.01.004","volume":"15","author":"RW Wong","year":"2004","unstructured":"Wong RW, Guillaud L (2004) The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15(2\u20133):147\u2013156","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"8014_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s13238-013-3043-8","volume":"4","author":"L Wang","year":"2013","unstructured":"Wang L, Liang B, Zhong Y (2013) Reduced EGFR level potentially mediates the A\u03b242-induced neuronal loss in transgenic fruit fly and mouse. Protein Cell 4(9):647\u2013649","journal-title":"Protein Cell"},{"key":"8014_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1326-8-35","volume":"8","author":"K Pr\u00fc\u00dfing","year":"2013","unstructured":"Pr\u00fc\u00dfing K, Voigt A, Schulz JB (2013) Drosophila melanogaster as a model organism for Alzheimer\u2019s disease. Mol Neurodegener 8:35","journal-title":"Mol Neurodegener"},{"issue":"15","key":"8014_CR33","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1073\/pnas.0909314107","volume":"107","author":"HC Chiang","year":"2010","unstructured":"Chiang HC, Wang L, Xie Z, Yau A, Zhong Y (2010) PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc Natl Acad Sci U S A 107(15):7060\u20137065","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8014_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbr.2017.03.044","volume":"328","author":"D \u00d6zbeyli","year":"2017","unstructured":"\u00d6zbeyli D, Sar\u0131 G, \u00d6zkan N, Karademir B, Y\u00fcksel M, \u00c7ilingir Kaya \u00d6T et al (2017) Protective effects of different exercise modalities in an Alzheimer\u2019s disease-like model. Behav Brain Res 328:159\u2013177","journal-title":"Behav Brain Res"},{"issue":"2","key":"8014_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mcn.2004.01.003","volume":"26","author":"O Raineteau","year":"2004","unstructured":"Raineteau O, Rietschin L, Gradwohl G, Guillemot F, G\u00e4hwiler BH (2004) Neurogenesis in hippocampal slice cultures. Mol Cell Neurosci 26(2):241\u2013250","journal-title":"Mol Cell Neurosci"},{"issue":"18","key":"8014_CR36","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1016\/S0021-9258(18)81641-6","volume":"264","author":"RP Schaudies","year":"1989","unstructured":"Schaudies RP, Christian EL, Savage CR (1989) Jr. Epidermal growth factor immunoreactive material in the rat brain. Localization and identification of multiple species. J Biol Chem 264(18):10447\u201310450","journal-title":"J Biol Chem"},{"issue":"2","key":"8014_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jnp.12028","volume":"7","author":"G Dirnberger","year":"2013","unstructured":"Dirnberger G, Jahanshahi M (2013) Executive dysfunction in Parkinson\u2019s disease: a review. J Neuropsychol 7(2):193\u2013224","journal-title":"J Neuropsychol"},{"key":"8014_CR38","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.arr.2024.102207","volume":"95","author":"E Arrigoni","year":"2024","unstructured":"Arrigoni E, Antoniotti P, Bellocchio V, Veronelli L, Corbo M, Pisoni A (2024) Neural alterations underlying executive dysfunction in Parkinson\u2019s disease: a systematic review and coordinate-based meta-analysis of functional neuroimaging studies. Ageing Res Rev 95:102207","journal-title":"Ageing Res Rev"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08014-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08014-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08014-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:57:34Z","timestamp":1744804654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08014-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["8014"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08014-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}